Heart failure after left atrial appendage occlusion: insights from the LAAOS-III randomized trialBackground Left atrial appendage removal or occlusion (LAAO) might increase the risk for heart failure (HF) due to the loss of the LAA`s reservoir function, active contraction and neuroendocrine ...
ACC.21 Dr.Richard Whitlockis a Professor of Surgery at McMaster University and a practicing cardiac surgeon at Hamilton Health Sciences. He is a lead investigator at the Population Health Research Institute and the principal investigator of the LAAOS III trial, along with co-principal investigator ...
El SM corresponde al conjunto de factores de riesgo cardiovascular, definidos como la “Adult Treatment Panel III” (ATP III) y que incluye a la resistencia a la insulina, la hipertensión arterial, la dislipidemia y marcadores antropométricos de obesidad abdominal. En estudios poblacionales,...
Correction to: Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial.cost analysisleft atrial appendage occlusionstrokeFIBRILLATIONBackgroundThe LAAOS III (Left Atrial Appendage Occlusion Study) clinical trial demonstrated that concomitant left ...
SURGICAL ABLATION OF ATRIAL FIBRILLATION IN 11 COUNTRIES: THE LAAOS III TRIALWe read with great interest the recent report on the time to cost effectiveness of different stroke reduction strategies in atrial fibrillation by Reddy et al. in your journal.1 This study evaluated the costs of ...